Advocacy

HFM works to increase and maintain access to lifesaving medication and quality and affordable healthcare for bleeding disorder patients in the state of Michigan.

HFM ADVOCATES FOR PATIENTS

HFM works to increase and maintain access to lifesaving medication and quality and affordable healthcare for bleeding disorder patients in the state of Michigan. We are currently monitoring the following issues in Michigan.

Lansing Days

March 23 & 24, 2021

Lansing Days, HFM’s annual state legislative day in May, provides an opportunity for constituents to educate their legislators on the needs and special interests of the bleeding disorders community. This event has unfortunately been cancelled for 2020, but will return in 2021.

Have you Registered to Vote?

YOUR VOTE MATTERS!

Use your voice as a bleeding disorders advocate.

HFM's Action Network

Support HFM in protecting the bleeding disorders community and sign up for action alerts.

  • This field is for validation purposes and should be left unchanged.

TAKE ACTION

CONTACT YOUR LOCAL REPRESENTATIVE TODAY

in the news

Get the latest HFM Advocacy News and Updates

Advocacy

Get Covered for 2021

Open Enrollment Starts November 1, 2020

Read More →
Advocacy

Health Can’t Wait

The coalition that is fighting to protect patients from harmful insurance tactics.

Read More →
Advocacy

How Will the Midterm Election Results Affect Healthcare in Michigan?

As the 2019 legislative cycle begins, HFM will be monitoring the introduction of bills and assessing their possible impact on the bleeding disorders community

Read More →

Learn more about federal issues at the Hemophilia Federation of America and the National Hemophilia Foundation

There are a multitude of policy issues facing the bleeding disorders community.

HFA and NHF​ support the community by providing information and tools to participate in monitoring, advocating, and supporting federal and state public policies that impact the lives of people living with bleeding disorders.

This site was made possible through a grant from Pfizer.

Skip to content